Diagnosing MonoMAC Syndrome in GATA2 Germline Mutated Myelodysplastic Syndrome via Next-Generation Sequencing in a Patient with Refractory and Complex Infection: Case Report and Literature Review

References

• Vinh DC, Patel SY, Uzel G, et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood. 2010;115(8):1519–1529. doi:10.1182/blood-2009-03-20862920040766
   PubMed Web of Science ®Google Scholar
• Bigley V, Haniffa M, Doulatov S, et al. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med. 2011;208(2):227–234. doi:10.1084/jem.2010145921242295
   PubMed Web of Science ®Google Scholar
• Destefano MS, Shoen CM, Cynamon MH. Therapy for Mycobacterium kansasii infection: beyond 2018. Front Microbiol. 2018;9:2271. doi:10.3389/fmicb.2018.0227130319580
   PubMed Web of Science ®Google Scholar
• Kazenwadel J, Secker GA, Liu YJ, et al. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood. 2012;119(5):1283–1291. doi:10.1182/blood-2011-08-37436322147895
   PubMed Web of Science ®Google Scholar
• Bödör C, Renneville A, Smith M, et al. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival. Haematologica. 2012;97(6):890–894. doi:10.3324/haematol.2011.05436122271902
   PubMed Web of Science ®Google Scholar
• Ishida H, Imai K, Honma K, et al. GATA-2 anomaly and clinical phenotype of a sporadic case of lymphedema, dendritic cell, monocyte, B- and NK-cell (DCML) deficiency, and myelodysplasia. Eur J Pediatr. 2012;171(8):1273–1276. doi:10.1007/s00431-012-1715-722430350
   PubMed Web of Science ®Google Scholar
• Portich JP, CONDINO NETO A, Faulhaber GAM. Humoral deficiency in a novel GATA2 mutation: a new clinical presentation successfully treated with hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2020;67(9):e28374. doi:10.1002/pbc.2837432558139
   PubMed Web of Science ®Google Scholar
• Mendes-de-almeida DP, Andrade FG, Borges G, et al. GATA2 mutation in long stand Mycobacterium kansasii infection, myelodysplasia and MonoMAC syndrome: a case-report. BMC Med Genet. 2019;20(1):64. doi:10.1186/s12881-019-0799-631035956
   PubMed Web of Science ®Google Scholar
• Simonis A, Fux M, Nair G, et al. Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency-a case report and comprehensive review of the literature. Ann Hematol. 2018;97(10):1961–1973. doi:10.1007/s00277-018-3388-429947977
   PubMed Web of Science ®Google Scholar
• Damian L, Sauvetre G, Marguet F, et al. Pseudo-sarcoidosis revealing MonoMAC syndrome. J Clin Immunol. 2018;38(7):739–741. doi:10.1007/s10875-018-0551-630280306
   PubMed Web of Science ®Google Scholar
• Sologuren I, Martinez-saavedra MT, Sole-violan J, et al. Lethal influenza in two related adults with inherited GATA2 deficiency. J Clin Immunol. 2018;38(4):513–526. doi:10.1007/s10875-018-0512-029882021
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Hattori H, Takagi E, et al. [MonoMAC syndrome patient developing myelodysplastic syndrome following persistent EBV infection]. Rinsho Ketsueki. 2018;59(3):315–322. doi:10.11406/rinketsu.59.315.Japanese.29618691
   PubMedGoogle Scholar
• Eguchi K, Ishimura M, Sonoda M, et al. Nontuberculous mycobacteria-associated hemophagocytic lymphohistiocytosis in MonoMAC syndrome. Pediatr Blood Cancer. 2018;65(7):e27017. doi:10.1002/pbc.2701729493060
   PubMed Web of Science ®Google Scholar
• Vila A, Dapas JI, Rivero CV, et al. Multiple opportunistic infections in a woman with GATA2 mutation. Int J Infect Dis. 2017;54:89–91. doi:10.1016/j.ijid.2016.11.40827894982
   PubMed Web of Science ®Google Scholar
• Ganapathi KA, Townsley DM, Hsu AP, et al. GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia. Blood. 2015;125(1):56–70. doi:10.1182/blood-2014-06-58034025359990
   PubMed Web of Science ®Google Scholar
• Chu VH, Curry JL, Elghetany MT, et al. MonoMAC versus idiopathic CD4+ lymphocytopenia. Comment to Haematologica. 2011;96(8):1221–5. Haematologica. 2012;97(4):e9–11; author reply e2. doi:10.3324/haematol.2011.058669
   Web of Science ®Google Scholar
• Sharma SK, Upadhyay V. Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases. Indian J Med Res. 2020;152(3):185–226. doi:10.4103/ijmr.IJMR_902_2033107481
   PubMed Web of Science ®Google Scholar
• Hatta M, Sultan AR, Tandirogang N, et al. Detection and identification of mycobacteria in sputum from suspected tuberculosis patients. BMC Res Notes. 2010;3:1–6. doi:10.1186/1756-0500-3-7220044935
   PubMedGoogle Scholar
• Sugihara E, Hirota N, Niizeki T, et al. Usefulness of bronchial lavage for the diagnosis of pulmonary disease caused by Mycobacterium avium-intracellulare complex (MAC) infection. J Infect Chemother. 2003;9(4):328–332. doi:10.1007/s10156-003-0267-114691654
   PubMedGoogle Scholar
• Buhler VB, Pollak A. Human infection with atypical acid-fast organisms; report of two cases with pathologic findings. Am J Clin Pathol. 1953;23(4):363–374. doi:10.1093/ajcp/23.4.36313040295
   PubMed Web of Science ®Google Scholar
• Kaustova J, Chmelik M, Ettlova D, et al. Disease due to Mycobacterium kansasii in the Czech Republic: 1984–89. Tuber Lung Dis. 1995;76(3):205–209. doi:10.1016/S0962-8479(05)80006-17548902
   PubMedGoogle Scholar
• Smith MB, Molina CP, Schnadig VJ, et al. Pathologic features of Mycobacterium kansasii infection in patients with acquired immunodeficiency syndrome. Arch Pathol Lab Med. 2003;127(5):554–560. doi:10.5858/2003-127-0554-PFOMKI12708897
   PubMed Web of Science ®Google Scholar
• Liu CJ, Huang HL, Cheng MH, et al. Outcome of patients with and poor prognostic factors for Mycobacterium kansasii-pulmonary disease. Respir Med. 2019;151:19–26. doi:10.1016/j.rmed.2019.03.01531047113
   PubMed Web of Science ®Google Scholar
• Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Thorax. 2000;55(3):210–218. doi:10.1136/thorax.55.3.21010679540
   PubMed Web of Science ®Google Scholar
• Griffith DE, Aksamit T, Brown-elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416.17277290
   PubMed Web of Science ®Google Scholar
• Santin M, Dorca J, Alcaide F, et al. Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease. Eur Respir J. 2009;33(1):148–152. doi:10.1183/09031936.0002400819118226
   PubMed Web of Science ®Google Scholar
• Shitrit D, Priess R, Peled N, et al. Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome. Eur J Clin Microbiol Infect Dis. 2007;26(10):679–684. doi:10.1007/s10096-007-0331-317629758
   PubMed Web of Science ®Google Scholar